in a clinical trial of low bone mineral density (BMD) among postmenopausal women, subjects were randomly assigned to three treatments. a placebo, a treatment drug at omg dose and the same treatment drug at 14 mg dose. Symptom severity was assessed by measuring BMD in lumbar spine. Based on the results, is there sufficient evidence to support the claim that the drug is effective in treating low bone mineral density? Performan appropriate hypothesis test. Follow the STATE-FORMULATE-SOLVE-CONCLUDE procedure and use the Minitab output shown below. Descriptive Statistics: Placebo, 6mg, 14mg Statistics Variable NN Mean SE Mean StDev Minimum Q1 Median Placebo 46 0-2.3418 0.0906 0.6142 -3.6219 -2.7792 -2.3498 6mg 44 0 -2.162 0.149 0.987 -4.234 -2.711 -2354 14mg 44 0 -2.135 0.116 0.768 -3.737 -2.700 -2.033 03 Maximum -1.9343 - 1,0904 -1.420 0.338 -1.565 -0.400 Probability Plot of Placebo, 6mg, 14mg Normal - 95% CI Placebo RS Placebo Mean 2.342 SD 06142 N 46 AD Value 0.002 10 Percent Maan 2.13 Siber 09 N 44 AD 0.416 P.Value 0.119 Hmo Smy M SO 07676 N 40 AD 0.245 Value 0.741 0 10 One-way ANOVA: Placebo, 6mg, 14mg Method Null hypothesis All means are equal Alternative hypothesis Not all means are equal Significance level a=0.05 HACK TO TOP . One-way ANOVA: Placebo, 6mg, 14mg Method Null hypothesis All means are equal Alternative hypothesis Not all means are equal Significance level a = 0.05 Equal variances were assured for the analysis. Factor Information Factor Levels Values Factor 3 Placebo, 6mg. 14mg Analysis of Variance Source DE Adj ss Ad MS F-Value P-value Factor 2 1.147 0.5735 0.89 0.412 Error 131 84.195 0.6427 Total 133 85.342 Tukey Simultaneous 95% Cls Difference of Means 6mg Placebo Ing. Placebo -0.50 02 0.00 0.50 Wanita il color thesis way Type your answer here. STATE FORMULATE Hs He: SOLVE: CONCLUDE: I in a clinical trial of low bone mineral density (BMD) among postmenopausal women, subjects were randomly assigned to three treatments. a placebo, a treatment drug at omg dose and the same treatment drug at 14 mg dose. Symptom severity was assessed by measuring BMD in lumbar spine. Based on the results, is there sufficient evidence to support the claim that the drug is effective in treating low bone mineral density? Performan appropriate hypothesis test. Follow the STATE-FORMULATE-SOLVE-CONCLUDE procedure and use the Minitab output shown below. Descriptive Statistics: Placebo, 6mg, 14mg Statistics Variable NN Mean SE Mean StDev Minimum Q1 Median Placebo 46 0-2.3418 0.0906 0.6142 -3.6219 -2.7792 -2.3498 6mg 44 0 -2.162 0.149 0.987 -4.234 -2.711 -2354 14mg 44 0 -2.135 0.116 0.768 -3.737 -2.700 -2.033 03 Maximum -1.9343 - 1,0904 -1.420 0.338 -1.565 -0.400 Probability Plot of Placebo, 6mg, 14mg Normal - 95% CI Placebo RS Placebo Mean 2.342 SD 06142 N 46 AD Value 0.002 10 Percent Maan 2.13 Siber 09 N 44 AD 0.416 P.Value 0.119 Hmo Smy M SO 07676 N 40 AD 0.245 Value 0.741 0 10 One-way ANOVA: Placebo, 6mg, 14mg Method Null hypothesis All means are equal Alternative hypothesis Not all means are equal Significance level a=0.05 HACK TO TOP . One-way ANOVA: Placebo, 6mg, 14mg Method Null hypothesis All means are equal Alternative hypothesis Not all means are equal Significance level a = 0.05 Equal variances were assured for the analysis. Factor Information Factor Levels Values Factor 3 Placebo, 6mg. 14mg Analysis of Variance Source DE Adj ss Ad MS F-Value P-value Factor 2 1.147 0.5735 0.89 0.412 Error 131 84.195 0.6427 Total 133 85.342 Tukey Simultaneous 95% Cls Difference of Means 6mg Placebo Ing. Placebo -0.50 02 0.00 0.50 Wanita il color thesis way Type your answer here. STATE FORMULATE Hs He: SOLVE: CONCLUDE